Monday, September 20


coronavirus, Covid 19, enfermedad de la gota, Estados Unidos, farmaco, FDA, Noticias, Salud

Gout Drug Could Help Fight COVID-19 | Digital Trends Spanish

The number of coronavirus infections has skyrocketed in recent weeks in the United States. For this reason, scientists are looking for other alternatives to try to stop the pandemic, beyond vaccines. In this sense, a group of researchers from the University of Georgia has highlighted the antiviral properties of probenecid, which is used to treat gout disease. The study published in Nature's Scientific Reports highlights that probenecid possesses broad antiviral properties, making it a good candidate not only for SARS-CoV-2, but for other common and deadly respiratory viruses such as RSV and influenza. Probenecid is an FDA-approved drug primarily used to treat gout, and is already widely available in the United States. This drug has been on the market for over 40 years and has minimal ...
biofármaco, científica mexicana, coronavirus, Covid 19, farmaco, Mexico, Noticias, Paola Castillo Juárez, Salud, Variante Delta

Mexicana develops biopharmaceutical to combat COVID-19 | Digital Trends Spanish

Paola Castillo Juárez, a scientist at the National Polytechnic Institute of Mexico (IPN), developed a biopharmaceutical that can be highly effective in combating COVID-19. This biopharmaceutical was developed from the design of four peptides, defined as small protein fragments, which have an efficacy of over 90 percent against the replication of COVID-19, once they are synthesized. The virology expert also highlighted that peptides are evaluated at the National Institute of Respiratory Diseases (INER) directly with the coronavirus isolated from patients. IPN."The results are surprising because the molecules developed focus on conserved sequences of the parts of the SARS-CoV-2 protein, which do not change even when the virus mutates and gives rise to new variants," explained the scientis...